Sanofi | SNY - Loan Capital




Sanofi reported 12.5B in Loan Capital for its fiscal quarter ending in June of 2024.

Loan Capital Change Date
AbbVie USD 58.75B 401M Sep/2024
Amgen USD 56.55B 305M Dec/2024
AstraZeneca USD 27.73B 2.29B Dec/2024
Bristol-Myers Squibb USD 47.6B 1.07B Dec/2024
Canopy Growth CAD 433.48M 125M Sep/2024
Corcept Therapeutics USD 6.36M 6.36M Sep/2024
Drreddys Laboratories INR 7.36B 1.13B Sep/2024
Eli Lilly USD 29.05B 5.32B Sep/2024
Galapagos EUR 8.24M 1000K Dec/2024
Genmab DKK 937M 41M Dec/2024
GlaxoSmithKline GBP 14.64B 1.39B Dec/2024
Glaxosmithkline GBP 13.24B 333M Sep/2024
Indivior 270M 2M Sep/2024
J&J USD 31.29B 347M Sep/2024
Merck USD 34.98B 265M Sep/2024
Novartis USD 22.93B 2.41B Dec/2024
Novartis USD 25.35B 4.12B Sep/2024
Pacira USD 385.89M 203.41M Sep/2024
Perrigo USD 4.31B 684.7M Sep/2024
Pfizer USD 56.92B 963M Sep/2024
Prestige Brands USD 1000M 60M Dec/2024
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 12.5B 1.84B Jun/2024
Sanofi 12.5B 1.84B Jun/2024
Supernus Pharmaceuticals USD 0 0 Jun/2024
UCB EUR 2.98B 12M Jun/2024
Zoetis USD 5.22B 1.35B Dec/2024